118 related articles for article (PubMed ID: 8973753)
1. Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial.
Schmitz G; Stumpe KO; Herrmann W; Weidinger G
Blood Press; 1996 Nov; 5(6):354-9. PubMed ID: 8973753
[TBL] [Abstract][Full Text] [Related]
2. Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.
Bönner G; Schmieder R; Chrosch R; Weidinger G
Cardiovasc Drugs Ther; 1997 Mar; 11(1):21-6. PubMed ID: 9140673
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
Sasaki J; Koga S; Uzawa H; Arakawa K
Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):402-7. PubMed ID: 2676872
[TBL] [Abstract][Full Text] [Related]
4. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
Yashiro A; Sugano M; Nakashima Y; Tasaki H; Kuroiwa A
Clin Ther; 1987; 10(1):98-106. PubMed ID: 2897239
[TBL] [Abstract][Full Text] [Related]
6. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
Rabkin SW; Huff MW; Newman C; Sim D; Carruthers SG
Hypertension; 1994 Aug; 24(2):241-8. PubMed ID: 8039850
[TBL] [Abstract][Full Text] [Related]
7. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
Eriksson JW; Jansson PA; Foley K; Lithell H
J Hypertens; 1996 Dec; 14(12):1469-75. PubMed ID: 8986932
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
[TBL] [Abstract][Full Text] [Related]
9. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
Houston MC; Burger C; Hays JT; Nadeau J; Swift L; Bradley CA; Olafsson L
Am Heart J; 1990 Jul; 120(1):172-9. PubMed ID: 2193493
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
Talseth T; Westlie L; Daae L; Vatle S
Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: a multicentre double-blind randomized controlled study.
Langenfeld MR; Bräutigam M; Weidinger G; Assmann I; Krönig B; Schmieder RE
J Hum Hypertens; 1996 Dec; 10(12):831-6. PubMed ID: 9140791
[TBL] [Abstract][Full Text] [Related]
13. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Talseth T; Westlie L; Daae LN
J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
Hakamäki T; Lehtonen A
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
[TBL] [Abstract][Full Text] [Related]
17. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
18. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
Houston MC; Olafsson L; Burger MC
Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of essential hypertension with the alpha-1 antagonist bunazosin retard. A multicenter, double-blind, placebo-controlled study].
Kirsten R; Weidinger G
Arzneimittelforschung; 1994 Jan; 44(1):13-6. PubMed ID: 7907871
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
